1 Kühlein T, Laux G, Gutscher A, Szecsenyi J. (2008). Kontinuierliche Morbiditätsregistrierung in der Hausarztpraxis – Vom Beratungsanlass zum Beratungsergebnis. München: Urban & Vogel GmbH.
2 Riemann D, Baum E, Cohrs S, Crönlein T, Hajak G, Hertenstein E, Spiegelhalder K. S3-Leitlinie Nicht erholsamer Schlaf/Schlafstörungen. Somnologie. 2017;21:2–44. doi: 10.1007/s11818-016-0097-x
3 Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Medicine Reviews. 2002;6:97–111.
doi: 10.1053/smrv.2002.0186
4 Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A. Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis. Sleep Medicine Reviews. 2015;30:11–24.
doi: 10.1016/j.smrv.2015.10.002
5 Baglioni C, Battagliese G, Feige B, Spiegelhalder K, Nissen C, Voderholzer U, Riemann D. Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. Journal of Affective Disorders. 2011;135:10–19.
doi:10.1016/j.jad.2011.01.011
6 Riemann D, Voderholzer U. Primary insomnia: a risk factor to develop depression. Journal of Affective Disorders. 2003;76:255–9.
doi: 10.1016/S0165-0327(02)00072-1
7 Weissmann MM, Greenwald S, Niño-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. General Hospital Psychiatry. 1997;19:245–50.
doi: 10.1016/S0163-8343(97)00056-X
8 Ritter P, Höfler M, Wittchen H, Lieb R, Bauer M, Pfennig A, Beesdo-Baum K. Disturbed sleep as risk factor for the subsequent onset of bipolar disorder datafroma10-yearprospective-longitudinal study among adolescents and young adults. Journal of psychiatric research. 2015;68:76–82.
doi: 10.1016/j.jpsychires.2015.06.005
9 Bernert RA, Turvey CL, Conwell Y, Joiner TE. Association of poor subjective sleep quality with risk for death by suicide during a 10-year-period – a longitudinal, population-based study of late life. JAMA Psychiatry 71. 2014;1129–37. doi: 10.1001/jamapsychiatry.2014.1126
10 Bjørngaard JH, Bjerkeset O, Romundstad P, Gunnell D. Sleeping problems and suicide in 75,000 Norwegian adults: a 20-year follow-up of the HUNT I study. Sleep. 2011;34:1155–9.
doi: 10.5665/SLEEP.1228
11 Malik S, Kanwar A, Sim LA, Prokop LJ, Wang Z, Benkhadra K. The association between sleep disturbances and suicidal behaviors in patients with psychiatric diagnoses: a systematic review and meta-analysis. Systematic Reviews. 2014;3:1–9.
doi: 10.1186/2046-4053-3-18
12 Pigeon WR, Pinquart M, Conner K. Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. The Journal of Clinical Psychiatry. 2012;73:1160–7.
doi: 10.4088/JCP.11r07586
13 Gujar N, McDonald S, Nishida M, Walker M. A role for REM sleep in recalibrating the sensitivity of the human brain to specific emotions. Cerebral Cortex. 2011;21:115–23.
doi: 10.1093/cercor/bhq064
14 Rosales-Lagarde A, Armony J, DelRío-Portilla Y, Trejo-Martínez D. Enhanced emotional reactivity after selective REM sleep deprivation in humans: an fMRI study. Frontiers in Behavioral Neuroscience, 6, 25. doi: 10.3389/fnbeh.2012.00025
15 Baglioni C, Spiegelhalder K, Lombardo C, Riemann D. Sleep and emotions: a focus on insomnia. Sleep Medicine Reviews. 2010;14:227–38. doi: 10.1016/j.smrv.2009.10.007
16 Pace-Schott E, Germain A, Milad M. Effects of sleep on memory for conditioned fear and fear extinction. Psychological Bulletin. 2015;141:835–57. doi: 10.1037/bul0000014
17 Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and deperssion. Sleep. 2007;30:873–80. doi: 10.1093/sleep/30.7.873
18 WHO. (1992). Kapitel V – F 51.0 Insomnien. In ICD-10 (international statistical classification of diseases and related health problems). WHO, Genf.
19 American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (DSM-5) (5th ed.). Arlington: American Psychiatric Publishing.
20 Fragebogen zur Tagesschläfrigkeit. (k.A.). Abgerufen am 18. Oktober 2018, von dgsm:
https://www.dgsm.de/downloads/fachinformationen/frageboegen/ess.pdf
21 Morin CM, Belleville G, Bélanger L, Ivers H. The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep. 2011;34:601–8.
doi: 10.1093/sleep/34.5.601
22 Regensburger Insomnieskala (2003). Abgerufen am 18. Oktober 2018, von dgsm:
https://www.dgsm.de/fachinformationen_frageboegen_ris.php?language=german
23 Yang CM, Spielman AJ, Huang YS. Insomnia. Current Treatment Options in Neurology. 2005;7:373.
doi: 10.1007/s11940-005-0030-2
24 Ebben MR, Spielman AJ. Non-pharmacological treatments for insomnia. Journal of Behavioral Medicine. 2009;32:244.
doi: 10.1007/s10865-008-9198-8
25 Holbrook AM, Crowther R, Lotter A, Cheng C, King D. Meta-analysis of benzodiazepine use in the treatment of insomnia. Canadian Medical Association Journal. 2000;162:225–33.
26 Nowell PD., Mazumdar S, Buysse D, Dew M. Benzodiazepines and zolpidem for chronic insomnia – a meta-analysis of treatment efficacy. JAMA. 1997;278:2170–7.
doi: 10.1001/jama.1997.03550240060035
27 Winkler A, Auer C, Doering B, Rief W. Drug treatment of primary insomnia: a meta-analysis of polysomnographic randomized controlled trials. CNS Drugs. 2014;28:799–816.
doi: 10.1007/s40263-014-0198-7
28 Kraus L, Pabst A. Epidemiologischer Suchtsurvey. Repräsentativerhebung zum Gebrauch und Missbrauch psychoaktiver Substanzen bei Erwachsenen in Deutschland. Sucht. 2010;56:309–84.
29 Hallfors DD, Saxe L. The dependence potential of short half-life benzodiazepines. American Journal of Public Health. 1993;83:1300–4.
doi: 10.2105/AJPH.83.9.1300
31 Soldatos CR, Dikeos D, Whitehead A. Tolerance and rebound insomnia with rapidly eliminated hypnotics: a meta-analysis of sleep laboratory studies. International Clinical Psychopharmacology. 1999;14:287–303.
doi: 10.1097/00004850-199914050-00004
31 Sun Y, Lin C, Lu C, Hsu C, Kao C. Association between zolpidem and suicide: a nationwide population-based case-control study. Mayo Clinic Proceedings. 2016;91:308–15.
doi: 10.1016/j.mayocp.2015.10.022
32 Joya FL, Kripke D, Loving R, Dawson A, Kline L. Meta-analyses of hypnotics and infections: eszopiclone, ramelteon, zaleplon, and zolpidem. Journal of Clinical Sleep Medicine. 2009;5:377–83.
33 Dassanayake T, Micie P, Carter G, Jones A. Effects of benzodiazepines, antidepressants, and opoids on driving. A systematic review and meta-analysis of epidemiological and experimental evidence. Drug Safety Journal. 2011;34:125–56.
doi: 10.2165/11539050-000000000-00000
34 Rapoport MJ, Lanctot K, Streiner D, Bedard M, Vingilis E, Murray B, Herrmann N. Benzodiazepine use and driving: a meta-analysis. Journal of clinical psychiatry. 2009;70:663–73.
doi: 10.4088/JCP.08m04325
35 Verster JC, Veldhuizen D, Patat A, Olivier B, Volkerts E. Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-the-road driving test. Current drug safety. 2006;1:63–71.
36 Lorenz N, Heim E, Roetger A, Birrer E, Maercker A. Randomized Controlled Trial to Test the Efficacy of an Unguided Online Intervention with Automated Feedback for the Treatment of Insomnia. Behavioural and Cognitive Psychotherapy. 2018;1–16.
doi: 10.1017/S1352465818000486
37 Burkard M, Birrer E, Schrieken B, Michael T. (2018). Efficacy of therapist-guided internet-delivered Cognitive Behavioral Therapy for Insomnia: A randomised controlled trial. Unpublished manuscript.
38 Zachariae R, Lyby MS, Ritterband LM, O’Toole MS. Efficacy of internet-delivered cognitive-behavioral therapy for insomnia – a systematic review and meta-analysis of randomized controlled trials. Sleep Medicine Reviews. 2016;30:1–10.
doi: 10.1016/j.smrv.2015.10.004